HDII (Hypertension Diagnostics) Additional Paid-In Capital: $28.46 Mil(As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Additional Paid-In Capital?

Hypertension Diagnostics HDII -99.00% Additional Paid-In Capital is $28.46 Mil as of Sep. 2019.


Hypertension Diagnostics's quarterly additional paid-in capital stayed the same from Mar. 2019 ($28.46 Mil) to Jun. 2019 ($28.46 Mil) and stayed the same from Jun. 2019 ($28.46 Mil) to Sep. 2019 ($28.46 Mil).

Hypertension Diagnostics's annual additional paid-in capital stayed the same from Dec. 2016 ($28.46 Mil) to Dec. 2017 ($28.46 Mil) and stayed the same from Dec. 2017 ($28.46 Mil) to Dec. 2018 ($28.46 Mil).

Hypertension Diagnostics Additional Paid-In Capital Related Terms

Hypertension Diagnostics Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Additional Paid-In Capital Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.00 28.46 28.46 28.46 28.46

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.46 28.46 28.46 28.46 28.46

Hypertension Diagnostics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of $28.46 Mil mean?
Hypertension Diagnostics (HDII) has a Additional Paid-In Capital of $28.46 Mil as of Sep. 2019. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Additional Paid-In Capital too high?
Hypertension Diagnostics' current Additional Paid-In Capital is $28.46 Mil.
How does Hypertension Diagnostics' Additional Paid-In Capital compare to ESTRF and OCLN?
Hypertension Diagnostics' Additional Paid-In Capital of $28.46 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Diversified Financial Services company?
A good Additional Paid-In Capital depends on the Diversified Financial Services industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Hypertension Diagnostics and its competitors. Hypertension Diagnostics's current Additional Paid-In Capital is $28.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Additional Paid-In Capital of $28.46 Mil. The current Additional Paid-In Capital is $28.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Additional Paid-In Capital is $28.46 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.